DNA Sequencing Global Market Report 2024

DNA sequencing involves determining the precise order or sequence of nucleotides (adenine, cytosine, guanine, and thymine) in a DNA molecule. This molecular biology and genetics technique is fundamental, enabling scientists to decipher the genetic code embedded within an organism's DNA.

The primary components of DNA sequencing are instruments, consumables, and services. Instruments, defined as mechanical tools or implements, particularly those used for delicate or precise operations, are employed in DNA sequencing to automate and execute the various steps involved in sequencing DNA samples. Technologies such as third-generation DNA sequencing, next-generation sequencing, and Sanger sequencing are applied in diagnostics, biomarkers and cancer research, reproductive health studies, personalized medicine initiatives, forensics, and other scientific domains. This technology is utilized by a diverse range of entities, including hospitals and healthcare organizations, academic and research institutions, as well as pharmaceutical and biotechnology companies.

The DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides DNA sequencing market statistics, including the DNA sequencing industry's global market size, regional shares, competitors with an DNA sequencing market share, detailed DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the DNA sequencing industry. This DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The DNA sequencing market size has grown rapidly in recent years. It will grow from $11.84 billion in 2023 to $13.68 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. The historical period's growth can be ascribed to factors such as the Human Genome Project, reductions in costs, the expansion of biomedical research, the adoption of clinical diagnostics, and the needs of pharmaceutical research and development.

The DNA sequencing market size is expected to see rapid growth in the next few years. It will grow to $24.49 billion in 2028 at a compound annual growth rate (CAGR) of 15.7%. The anticipated growth in the forecast period can be attributed to advancements in next-generation sequencing (NGS), the implementation of point-of-care sequencing, initiatives in population genomics, integration of artificial intelligence (AI) and machine learning, and the adoption of precision medicine. Key trends expected in the forecast period encompass progress in single-cell sequencing, a focus on epigenetics and transcriptomics, the development of liquid biopsy techniques, considerations related to ethics and privacy, and the incorporation of nanotechnology.

The anticipated growth in the DNA sequencing market is expected to be driven by the rising prevalence of cancer. Cancer, characterized by uncontrolled cell growth impacting various organs, is a leading cause of morbidity and mortality globally. DNA sequencing plays a pivotal role in identifying genetic mutations, comprehending tumor biology, and guiding treatment decisions, ultimately enhancing outcomes in cancer care. Notably, Macmillan Cancer Support reported in October 2022 that the number of individuals with cancer was 3 million in 2020 and is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the escalating prevalence of cancer is a key factor propelling the growth of the DNA sequencing market.

The growing demand for personalized medicine is poised to drive the expansion of the DNA sequencing market. Personalized medicine, an innovative approach considering individual variations in genes, environments, and lifestyles, has gained prominence in medical treatment and healthcare. The emphasis on tailoring treatments to an individual's genetic makeup has led to an increased need for DNA sequencing technologies to identify specific genetic variations and guide treatment decisions. In 2022, The Personalized Medicine Coalition reported that personalized medicines accounted for 35% of newly approved new molecular entities (NMEs) in 2021. Therefore, the escalating demand for personalized medicine is a significant factor fueling the growth of the DNA sequencing market.

An emerging trend gaining traction in the DNA sequencing market is the progress in single-cell DNA sequencing technologies. Leading companies in the market are embracing innovative technologies to maintain their competitive positions. For example, in May 2023, Mission Bio Inc., a biotechnology company based in the US, introduced Tapestri v3, an advanced version of its high-throughput single-cell DNA and multi-omics analysis platform. Tapestri v3 incorporates breakthrough improvements in chemistry, significantly enhancing the detection of rare cells across various applications. Its improved cell capture capabilities allow researchers to identify previously undetectable single cells, providing a deeper understanding of diseases. This enhanced technology is particularly promising for applications such as measurable residual disease (MRD) assessment in cancer, where Tapestri v3 enables the detection of relapse-driving clones that were previously overlooked. Additionally, it offers advantages for developers of cell and gene therapy by enabling quality assessment at the single-cell level.

Major players in the DNA sequencing market are directing their efforts towards developing innovative solutions, including production-scale sequencers. These advanced DNA sequencing machines are designed for large-scale and high-throughput sequencing, facilitating the efficient processing of significant volumes of genetic material in research, clinical, or industrial settings. For instance, in September 2022, Illumina, Inc., a US-based biotechnology company, launched the 'NovaSeq X Series,' a new production-scale sequencer capable of sequencing more than 20,000 genomes per year with the highest levels of accuracy. This sustainable high-throughput sequencer achieves a 90% reduction in packaging, a 50% reduction in plastic waste, and eliminates the need for dry ice shipments, enhancing global access to genomic medicine and demonstrating a commitment to environmental responsibility.

In August 2021, ProPhase Labs Inc., a US-based next-generation biotech, genomics, and diagnostics company, completed the acquisition of Nebula Genomics for $14.6 million. Through this acquisition, ProPhase Labs aims to integrate Nebula's whole-genome sequencing services with its existing clinical diagnostic testing services, enhancing its capabilities and offerings in genetic testing. Nebula Genomics is a US-based company specializing in whole-genome sequencing services.

Major companies operating in the DNA sequencing market report are F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics, Myriad Genetics Inc., Natera Inc., 10x Genomics Inc., GenScript Biotech Corporation, Novogene Corporation, Twist Bioscience, Genewiz LLC, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., LI-COR Inc., MGI Tech Co. Ltd., Zymo Research Corporation, Igenomix, Codex DNA, GenapSys Inc., SeqOnce Biosciences Inc.

North America was the largest region in the DNA sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the DNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The DNA sequencing market consists of revenues earned by entities by providing bioinformatics and data analysis software and sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA sequencing market also includes sales of DNA sequencing kits, sequencing reagents, and laboratory equipment used in providing DNA sequencing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Instruments; Consumables; Services
• 2) By Technology: Third Generation DNA Sequencing; Next-Generation Sequencing; Sanger Sequencing
• 3) By Application: Diagnostics; Biomarkers And Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
• 1) By End User: Hospitals And Healthcare Organizations; Academics And Research Institutions; Pharmaceutical And Biotechnology Companies; Other End Users
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Abbott Laboratories Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.